(9alpha,13alpha,14alpha)-3-Methoxy-17-methylmorphinan(CAS: 125-71-3)

The compound (9alpha,13alpha,14alpha)-3-Methoxy-17-methylmorphinan (CAS: 125-71-3) has a crystalline form with a molecular weight of approximately 279.35 g/mol. It is slightly soluble in water but more soluble in organic solvents like ethanol and acetone. Chemically, it exhibits moderate reactivity, particularly in acidic and basic conditions. It is not highly reactive but should be handled with care.

(9alpha,13alpha,14alpha)-3-Methoxy-17-methylmorphinan (CAS: 125-71-3) is typically synthesized through a multi-step process involving the modification of morphine to introduce the methoxy and methyl groups. Commonly, this involves coupling reactions, methylation steps, and cyclization. The synthesis often uses catalysts like palladium and ligands to achieve high selectivity and yield.

(9alpha,13alpha,14alpha)-3-Methoxy-17-methylmorphinan (CAS: 125-71-3) is primarily used in the pharmaceutical industry for the development of certain pain management and anti-diarrheal medications. It may also find applications in research and development for new drug formulations, although its specific uses vary based on the purity and structure of the compound.

When handling (9alpha,13alpha,14alpha)-3-Methoxy-17-methylmorphinan (CAS: 125-71-3), it is important to wear appropriate personal protective equipment (PPE) such as gloves, goggles, and a laboratory coat. Work should be conducted in a fume hood to avoid inhalation. In the event of a spill, it should be immediately cleaned up according to the Material Safety Data Sheet (MSDS). The compound should be stored in a cool, dry place, away from heat sources and incompatible materials.